REPLIGEN 23/28 CVREPLIGEN 23/28 CVREPLIGEN 23/28 CV

REPLIGEN 23/28 CV

No trades
See on Supercharts

Key terms


Outstanding amount
0.00USD
Face value
1,000.00USD
Minimum denomination
1,000.00USD
Coupon
1.00% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
Maturity date
Dec 15, 2028
Term to maturity

About REPLIGEN 23/28 CV


Sector
Health Technology
Issue date
Dec 14, 2023
Home page
Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.